Furosemide‑Induced Hyperuricemia and Gout Risk

Mechanistic Contributions

Volume depletion caused by furosemide enhances proximal tubular sodium reabsorption, which simultaneously increases uric acid reabsorption via coupled transport mechanisms, thereby raising serum urate levels. [Journal of Hepatology 2018] 1
Activation of tubuloglomerular feedback and renin release by furosemide can lower glomerular filtration rate, reducing uric acid clearance; this effect is amplified in patients with pre‑existing renal impairment. [The Canadian Journal of Cardiology 2007] 3

The 2012 American College of Rheumatology (ACR) gout guideline advises discontinuing non‑essential medications that elevate serum urate, with loop diuretics identified as a primary culprit. [Arthritis Care & Research 2012] 2
The ACR guideline also recommends avoiding concomitant use of furosemide with other agents that impair uric acid excretion (e.g., thiazides, low‑dose aspirin, cyclosporine) unless absolutely necessary; when combination therapy is unavoidable, prophylactic urate‑lowering therapy should be considered. [Arthritis Care & Research 2012] 2

Patients with baseline hyperuricemia (serum urate > 6 mg/dL in women or > 7 mg/dL in men) are at heightened risk for furosemide‑induced gout. [Annals of the Rheumatic Diseases 2006] 7
Chronic or high‑dose loop diuretic therapy further increases gout risk. [American Journal of Respiratory and Critical Care Medicine 2003] 8
Impaired renal function (estimated GFR < 60 mL/min/1.73 m²) compounds the hyperuricemic effect of furosemide. [The Canadian Journal of Cardiology 2007] 3
A family history of early‑onset gout or prior urolithiasis also identifies a susceptible subgroup. [Annals of the Rheumatic Diseases 2006] 7

Baseline and periodic serum uric acid measurements are recommended for all patients initiating chronic furosemide therapy. [Arthritis Care & Research 2012] 2
Serum electrolytes, creatinine, and BUN should be checked every 3–7 days during dose escalation to detect electrolyte disturbances and worsening renal function. [The Canadian Journal of Cardiology 2007; Circulation 2013] [3] [6]
In advanced heart failure or acute decompensation, monitoring should be intensified to every 1–3 days. [The Canadian Journal of Cardiology 2007] 5
Patients should be assessed regularly for clinical signs of gout (joint pain, swelling, acute arthritis). [Annals of the Rheumatic Diseases 2006; Arthritis Care & Research 2012] [7] [2]

Discontinuation of furosemide solely because of asymptomatic hyperuricemia is discouraged in heart‑failure patients, as the morbidity and mortality associated with volume overload outweigh the risks of silent hyperuricemia. [Circulation 2013] 6
When hyperuricemia becomes problematic, switching to torsemide may lessen the impact on uric acid metabolism; the 2018 European Association for the Study of the Liver (EASL) guidelines suggest torsemide for patients with inadequate response to furosemide. [Journal of Hepatology 2018] 1
Adding an aldosterone antagonist (e.g., spironolactone 12.5–25 mg daily) can reduce the required dose of loop diuretics, though it does not directly lower serum urate. [Journal of Hepatology 2018; Circulation 2013] [1] [6]